ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2558

DNA Methylation-Dependent Regulation of Cathepsin E Gene Expression By the Transcription Factor Kaiso in MRL/Lpr Mice

Sumie Hiramatsu1, Katsue S. Watanabe1, Yoshinori Matsumoto2, Yosuke Asano2, Sonia Zeggar1, Keiji Ohashi1, Michiko Morishiata3, Eri Katsuyama1, Takayuki Katsuyama1, Haruki Watanabe1, Mariko Narazaki1, Noriko Tatebe1, Tomoko Kawabata1, Ken-ei Sada1 and Jun Wada1, 1Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism,, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 3Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: SLE and epigenetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Lupus Erythematosus – Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To identify new candidate genes regulated by DNA methylation and involved in the pathogenesis of systemic lupus erythematosus (SLE), we integrated genome-wide DNA methylation analysis and mRNA expression profiling in CD4+ splenic T cells derived from MRL/lpr lupus-prone mice (MRL) and C57BL6/J mice (B6) as a control.

Methods: Chromatin immunoprecipitation (ChIP)-PCR was used to investigate the transcription factors binding to CGCG methylation sites. Murine T lymphoma cell line, EL-4, was treated with DNA methyltransferase inhibitor, 5-Azacytidine (5-azaC) or histone deacetylase (HDAC) inhibitor, Trichostatin A (TSA) for in vitro study. To analyze the expression levels of mRNAs, quantitative real-time PCR (qPCR) was performed on a Step One Plus Real-Time PCR System (Applied Biosystems) using the TaqMan Gene Expression assays. To identify the function of Ctse, the Ctse gene was depleted by siRNA in EL4 cells stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin, and measured IL-10 in cell culture supernatants by ELISA . To examine the expression levels of Il-10 and Ctse in CD4+ T cell subsets in peripheral blood mononuclear cell (PBMC) from 15 SLE patients and 6 healthy controls.

Results: We show that expression levels of Ctse transcripts are elevated in MRL T cells compared to that in B6 T cells and that the 583 bp region in the 1st intron in the Ctse gene is hypomethylated. Bisulfite sequencing show that the CGCG motif in this region is hypomethylated in MRL cells. Kaiso, known to specifically recognize the methylated DNA motif (mCGCG) through the C2H2 zinc-finger domains, recruits the SMRT (Silencing Mediator of Retinoic acid and Thyroid hormone receptors) / N-CoR (Nuclear hormone receptor Co-Repressor) HDAC3 (Histone deacetylase 3) complex, leading to suppression of its target gene. To demonstrate that Kaiso and HDAC3 are components of the transcriptional complex regulating Ctse expression, we performed ChIP of the endogenous Ctse promoter in CD4+ T cells and observed strong enrichment of a Ctse-derived amplicon including the CGCG motif in both Kaiso and HDAC3 chromatin immunoprecipitates. Moreover, we found that the recruitment of Kaiso to the Ctse promoter was suppressed in MRL cells compared to B6 cells. Additionally, EL4 cells treated with 5-azaC or TSA showed the reduced recruitment of both Kaiso and HDAC3 to the motif. . Moreover, we observed that depletion of the Ctse gene by siRNA in EL4 cells results in reduction of IL-10 expression in cell culture supernatants by ELISA and that the expression level of Il-10 transcripts are up-regulated in MRL T cells compared to B6. Lastly, we observed that In CD4+ T cell subsets in PBMC from SLE, the expression levels of CTSE and IL-10 transcripts were elevated in CD4+ T cells from SLE patients compared to that in healthy controls.

Conclusion: Our present study provides evidence that DNA methylation-mediated recruitment of both Kaiso and HDAC3 to the Ctse promoter regulates expression of Ctse and that demethylation of this promoter and subsequent elevation of Ctse and Il-10 expression may be the pathogenesis of SLE.


Disclosure: S. Hiramatsu, None; K. S. Watanabe, None; Y. Matsumoto, None; Y. Asano, None; S. Zeggar, None; K. Ohashi, None; M. Morishiata, None; E. Katsuyama, None; T. Katsuyama, None; H. Watanabe, None; M. Narazaki, None; N. Tatebe, None; T. Kawabata, None; K. E. Sada, None; J. Wada, None.

To cite this abstract in AMA style:

Hiramatsu S, Watanabe KS, Matsumoto Y, Asano Y, Zeggar S, Ohashi K, Morishiata M, Katsuyama E, Katsuyama T, Watanabe H, Narazaki M, Tatebe N, Kawabata T, Sada KE, Wada J. DNA Methylation-Dependent Regulation of Cathepsin E Gene Expression By the Transcription Factor Kaiso in MRL/Lpr Mice [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/dna-methylation-dependent-regulation-of-cathepsin-e-gene-expression-by-the-transcription-factor-kaiso-in-mrllpr-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dna-methylation-dependent-regulation-of-cathepsin-e-gene-expression-by-the-transcription-factor-kaiso-in-mrllpr-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology